APA (7th ed.) Citation

Han, K., Benn, P., Sievers, J., Dorey, D., Warwick‐Sanders, M., Hareedy, R., . . . Spreen, W. R. (2025). A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV. Clinical Pharmacology in Drug Development, 14(7), 528. https://doi.org/10.1002/cpdd.1538

Chicago Style (17th ed.) Citation

Han, Kelong, et al. "A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV." Clinical Pharmacology in Drug Development 14, no. 7 (2025): 528. https://doi.org/10.1002/cpdd.1538.

MLA (9th ed.) Citation

Han, Kelong, et al. "A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV." Clinical Pharmacology in Drug Development, vol. 14, no. 7, 2025, p. 528, https://doi.org/10.1002/cpdd.1538.